Literature DB >> 20574450

Targeting the tumour vasculature: insights from physiological angiogenesis.

Alicia S Chung1, John Lee, Napoleone Ferrara.   

Abstract

The cardiovascular system ensures the delivery of nutrients, oxygen, and blood and immune cells to all organs and tissues: it is also responsible for the removal of waste metabolites. The vascular system develops and matures through two tightly regulated processes: vasculogenesis and angiogenesis. Angiogenesis is active only under specific physiological conditions in healthy adults but the vasculature can be aberrantly activated to generate new blood vessels during pathological conditions such as cancer and chronic inflammation. In this Opinion article we discuss the parallels and differences in the angiogenic process under either a physiological or a pathological state, especially tumorigenesis.

Entities:  

Mesh:

Year:  2010        PMID: 20574450     DOI: 10.1038/nrc2868

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  159 in total

1.  Blood vessel maturation: vascular development comes of age.

Authors:  D C Darland; P A D'Amore
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 2.  Oxygen homeostasis.

Authors:  Gregg L Semenza
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 May-Jun

3.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

Review 4.  Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.

Authors:  Michele De Palma; Craig Murdoch; Mary Anna Venneri; Luigi Naldini; Claire E Lewis
Journal:  Trends Immunol       Date:  2007-11-05       Impact factor: 16.687

5.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

8.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

Review 10.  Why are tumour blood vessels abnormal and why is it important to know?

Authors:  J A Nagy; S-H Chang; A M Dvorak; H F Dvorak
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  256 in total

1.  Inorganic polyphosphate induces accelerated tube formation of HUVEC endothelial cells.

Authors:  Werner E G Müller; Maximilian Ackermann; Shunfeng Wang; Meik Neufurth; Rafael Muñoz-Espí; Qingling Feng; Heinz C Schröder; Xiaohong Wang
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

Review 2.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

3.  CTCF-dependent chromatin insulator as a built-in attenuator of angiogenesis.

Authors:  Jianrong Lu; Ming Tang
Journal:  Transcription       Date:  2012-03-01

4.  Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.

Authors:  Napoleone Ferrara
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

5.  Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.

Authors:  Guanglei Zhuang; Xiumin Wu; Zhaoshi Jiang; Ian Kasman; Jenny Yao; Yinghui Guan; Jason Oeh; Zora Modrusan; Carlos Bais; Deepak Sampath; Napoleone Ferrara
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

6.  Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Authors:  Xiang H-F Zhang; Xin Jin; Srinivas Malladi; Yilong Zou; Yong H Wen; Edi Brogi; Marcel Smid; John A Foekens; Joan Massagué
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

7.  VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Authors:  D Zhao; C Pan; J Sun; C Gilbert; K Drews-Elger; D J Azzam; M Picon-Ruiz; M Kim; W Ullmer; D El-Ashry; C J Creighton; J M Slingerland
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

Review 8.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

9.  Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging.

Authors:  Peter A Jarzyna; Lisette H Deddens; Benjamin H Kann; Sarayu Ramachandran; Claudia Calcagno; Wei Chen; Anita Gianella; Rick M Dijkhuizen; Arjan W Griffioen; Zahi A Fayad; Willem J M Mulder
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 10.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.